Can You Stop Mounjaro for a Week? What to Expect

Tirzepatide has a half-life of roughly five days, so its effects taper gradually over the week after a missed dose rather than stopping all at once.
Appetite often returns noticeably within days of a missed injection, most people find hunger and food noise increase before the week is out.
A one-week break is unlikely to cause clinical harm for most people, but restarting after a break of more than two weeks may require going back to a lower dose to avoid side effects.
Any planned break from treatment should be discussed with your prescriber, who can advise on timing, restarting strategy, and what to watch for.

Stopping Mounjaro for a week is something many people on treatment end up considering — a holiday, a planned procedure, a pen that hasn't arrived in time. The honest answer is that a short break won't erase your progress, but it isn't without effect either. Mounjaro (tirzepatide) stays active in your body for roughly a week after each dose, so a single missed injection doesn't mean an immediate cliff edge. That said, your appetite, blood sugar regulation, and gastric emptying can all shift noticeably once the medicine clears your system, particularly if you've been on a higher dose. Whether stopping is sensible depends on your reason, your current dose, and your clinical picture — which is always a conversation to have with your prescriber rather than a unilateral decision. These are prescription-only medicines, and any planned break is worth raising before you take it.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What a week off Mounjaro actually does to your body and your treatment

You've missed a dose, or you're planning to. Here's what's happening inside

Picture this: your pen arrived late, or you're flying out on Thursday and the timing just doesn't work. You miss your usual injection day and you're wondering whether to skip the whole week or try to catch up. It's one of the questions our prescribers hear most weeks, and the answer starts with how tirzepatide actually works in the body.

Tirzepatide has a half-life of around five days. That means roughly half the active medicine is still circulating a week after your last dose. The appetite suppression, the slowing of gastric emptying, the reduction in food noise, these don't vanish the moment you're due your next pen. They fade. Most people notice the shift somewhere between day four and day seven: hunger comes back, portions that felt comfortable start feeling less satisfying, and the mental quiet around food begins to lift.

For a fuller picture of how the medicine works at each stage, the tirzepatide overview covers the dual GIP and GLP-1 mechanism in plain terms. The NHS's patient information for tirzepatide also explains what to do if you miss a dose, the short version is that if your missed injection was less than four days ago, you can take it as soon as you remember; beyond that, skip it and wait for your next scheduled dose. Never double up.

A single week's gap, then, isn't medically catastrophic for most people. But it isn't nothing, either, and it's worth understanding what's actually shifting before you decide.

What tends to change during the break, and what usually doesn't

The most immediate thing people notice is appetite. The satiety signalling that tirzepatide supports fades as the drug clears, and for many people that means returning hunger feels sharper than expected, partly because your body has adapted to eating less, so the contrast is striking. Some people describe it as a reminder of what eating used to feel like before treatment. That can be unsettling, particularly if you're mid-holiday and food is very much part of the occasion.

Weight itself tends to hold reasonably well across a single week off, especially if you're consciously maintaining the eating habits you've built on treatment. The medicine has helped reshape those habits; it doesn't take them away the moment it fades. People who are further into treatment and have established a strong routine tend to manage a week's break better than those who are still early in the process, if you're at week five or week six, your habits may be less consolidated than someone six months in.

What doesn't typically change in one week is your overall trajectory. Clinical trial data and real-world experience both suggest that brief, planned breaks don't unravel progress. The concern arises when breaks extend. If you stop Mounjaro for two weeks or more, you may need to restart at a lower dose to avoid the gastrointestinal side effects that come with re-introduction at a higher strength, your tolerance resets faster than you'd expect. Our guide to stopping for two weeks covers that scenario in detail.

For context on cost and planning, the Mounjaro price comparison page explains what UK private treatment typically involves, including the clinical review that covers restarting decisions.

When stopping might be the right call, and when it warrants a conversation first

There are situations where pausing Mounjaro is clinically sensible, not just practically unavoidable. Surgery is one: NHS England guidance is clear that your healthcare team and anaesthetist need to know you're taking a GLP-1 medicine before any procedure, and your surgical team may ask you to stop in advance. A planned break in that context isn't optional, it's part of safe perioperative care.

Severe illness with significant vomiting or diarrhoea is another. The gastrointestinal side effects of tirzepatide can compound dehydration from illness, and your prescriber may advise pausing until you've recovered. That's different from skipping a dose because of travel logistics, but the principle is the same: the decision belongs with a clinician who knows your case.

What's less advisable is stopping because you're struggling with side effects and hoping a week off resets things. Sometimes it does, briefly, but it doesn't address the underlying issue, and reintroduction at the same dose can bring those side effects straight back. A conversation with your prescriber is a much better route than a self-managed break. If you're thinking about whether this treatment is right for you long-term, the page on how long Mounjaro is intended to be taken gives an honest account of what the evidence actually shows.

If you'd like to explore starting treatment (or to review your current plan with a prescriber) you can check your eligibility with our clinical team. Every consultation is reviewed the same day by a real prescriber, not automated software, and there's no obligation to proceed.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions